{"id":"https://openalex.org/W4239477346","doi":"https://doi.org/10.1038/s41386-018-0213-7","title":"TAK-137, an AMPA-R potentiator with little agonistic effect, has a wide therapeutic window","display_name":"TAK-137, an AMPA-R potentiator with little agonistic effect, has a wide therapeutic window","alternate_titles":[],"publication_year":2018,"publication_date":"2018-09-12","ids":{"openalex":"https://openalex.org/W4239477346","doi":"https://doi.org/10.1038/s41386-018-0213-7"},"language":"en","primary_location":{"id":"doi:10.1038/s41386-018-0213-7","doi":"https://doi.org/10.1038/s41386-018-0213-7","is_oa":false,"landing_page_url":"https://doi.org/10.1038/s41386-018-0213-7","pdf_url":null,"source":{"id":"https://openalex.org/S175030738","display_name":"Neuropsychopharmacology","issn_l":"0893-133X","issn":["0893-133X","1740-634X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4239477346"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004843749","display_name":"Akiyoshi Kunugi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Akiyoshi Kunugi","raw_affiliation_strings":["Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074210227","display_name":"Maiko Tanaka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maiko Tanaka","raw_affiliation_strings":["Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102748351","display_name":"Atsushi Suzuki","orcid":"https://orcid.org/0000-0002-8747-1635","observed_orcids":["https://orcid.org/0000-0002-8747-1635"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Atsushi Suzuki","raw_affiliation_strings":["Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088935807","display_name":"Yasukazu Tajima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yasukazu Tajima","raw_affiliation_strings":["Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066250028","display_name":"Noriko Suzuki","orcid":"https://orcid.org/0000-0001-9130-3944","observed_orcids":["https://orcid.org/0000-0001-9130-3944"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Noriko Suzuki","raw_affiliation_strings":["Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075989323","display_name":"Motohisa Suzuki","orcid":"https://orcid.org/0000-0002-7083-5877","observed_orcids":["https://orcid.org/0000-0002-7083-5877","https://orcid.org/0000-0001-8416-2733"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Motohisa Suzuki","raw_affiliation_strings":["Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103054965","display_name":"Shinji Nakamura","orcid":"https://orcid.org/0000-0003-1783-3319","observed_orcids":["https://orcid.org/0000-0003-1783-3319"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shinji Nakamura","raw_affiliation_strings":["Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086300788","display_name":"Haruhiko Kuno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Haruhiko Kuno","raw_affiliation_strings":["Bio-Molecular Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bio-Molecular Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077301124","display_name":"Akihiro Yokota","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Akihiro Yokota","raw_affiliation_strings":["Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042044281","display_name":"Satoshi Sogabe","orcid":"https://orcid.org/0000-0003-2393-9582","observed_orcids":["https://orcid.org/0000-0003-2393-9582"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Satoshi Sogabe","raw_affiliation_strings":["Bio-Molecular Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bio-Molecular Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102932433","display_name":"Yohei Kosugi","orcid":"https://orcid.org/0000-0001-9318-4723","observed_orcids":["https://orcid.org/0000-0001-9318-4723"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yohei Kosugi","raw_affiliation_strings":["Drug Metabolism and Pharmacokinetics Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Metabolism and Pharmacokinetics Research Laboratories, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026185084","display_name":"Yasuyuki Awasaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yasuyuki Awasaki","raw_affiliation_strings":["Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Research and Evaluation, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053799847","display_name":"Tomohiro Kaku","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tomohiro Kaku","raw_affiliation_strings":["Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075620105","display_name":"Haruhide Kimura","orcid":"https://orcid.org/0000-0002-8292-3647","observed_orcids":["https://orcid.org/0000-0002-8292-3647"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Haruhide Kimura","raw_affiliation_strings":["Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan. haruhide.kimura@takeda.com","Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan. haruhide.kimura@takeda.com","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited, Fujisawa, Japan","institution_ids":["https://openalex.org/I44892455"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5075620105"],"corresponding_institution_ids":["https://openalex.org/I44892455"],"apc_list":{"value":5290,"currency":"USD","value_usd":5290},"apc_paid":null,"fwci":1.237,"has_fulltext":true,"cited_by_count":30,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.74540168,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"44","issue":"5","first_page":"961","last_page":"970"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ampa-receptor-potentiators","display_name":"AMPA receptor potentiators","score":0.9390000104904175},{"id":"https://openalex.org/keywords/brain-derived-neurotrophic-factor","display_name":"brain-derived neurotrophic factor","score":0.972000002861023},{"id":"https://openalex.org/keywords/cognitive-enhancement","display_name":"cognitive enhancement","score":0.7540000081062317},{"id":"https://openalex.org/keywords/neural-progenitor-cell-proliferation","display_name":"neural progenitor proliferation","score":0.9850000143051147},{"id":"https://openalex.org/keywords/primary-neurons","display_name":"primary neurons","score":0.48500001430511475}],"concepts":[{"id":"https://openalex.org/C164718446","wikidata":"https://www.wikidata.org/wiki/Q7234839","display_name":"Potentiator","level":2,"score":0.9834473133087158},{"id":"https://openalex.org/C187898756","wikidata":"https://www.wikidata.org/wiki/Q395324","display_name":"Agonistic behaviour","level":3,"score":0.7686511278152466},{"id":"https://openalex.org/C160268369","wikidata":"https://www.wikidata.org/wiki/Q295251","display_name":"AMPA receptor","level":4,"score":0.6992900967597961},{"id":"https://openalex.org/C46622094","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic window","level":2,"score":0.6855024099349976},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5062403082847595},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.4542853832244873},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2562319338321686},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.25482234358787537},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2116277515888214},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.18178176879882812},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.1628555953502655},{"id":"https://openalex.org/C2779448149","wikidata":"https://www.wikidata.org/wiki/Q191797","display_name":"Aggression","level":2,"score":0.160200297832489},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07154282927513123}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1038/s41386-018-0213-7","doi":"https://doi.org/10.1038/s41386-018-0213-7","is_oa":false,"landing_page_url":"https://doi.org/10.1038/s41386-018-0213-7","pdf_url":null,"source":{"id":"https://openalex.org/S175030738","display_name":"Neuropsychopharmacology","issn_l":"0893-133X","issn":["0893-133X","1740-634X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychopharmacology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W78616893","https://openalex.org/W1557933310","https://openalex.org/W1652624724","https://openalex.org/W1964466640","https://openalex.org/W1965798600","https://openalex.org/W1966681799","https://openalex.org/W1973327401","https://openalex.org/W1976289522","https://openalex.org/W1978817835","https://openalex.org/W1986541571","https://openalex.org/W1999107947","https://openalex.org/W2000300989","https://openalex.org/W2003038730","https://openalex.org/W2006406301","https://openalex.org/W2021601682","https://openalex.org/W2027436298","https://openalex.org/W2037852973","https://openalex.org/W2047432512","https://openalex.org/W2050493044","https://openalex.org/W2063461600","https://openalex.org/W2066358338","https://openalex.org/W2077934871","https://openalex.org/W2080705534","https://openalex.org/W2106721061","https://openalex.org/W2139012908","https://openalex.org/W2163851282","https://openalex.org/W2171516606","https://openalex.org/W2171953679","https://openalex.org/W2216603275","https://openalex.org/W2409709657","https://openalex.org/W4248992830"],"related_works":["https://openalex.org/W2972575029","https://openalex.org/W3179903618","https://openalex.org/W3191317216","https://openalex.org/W4248992830","https://openalex.org/W6906710938","https://openalex.org/W4251751322","https://openalex.org/W2106721061","https://openalex.org/W2038155344","https://openalex.org/W3125481334"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4239477346","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":6}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2022-05-12T00:00:00"}
